ArticleFrontiers in oncology2021

Analysis of the Safety of Pegfilgrastim Addition in Bleomycin, Etoposide, and Cisplatin Treatment Patients With Germ Cell Tumors.

Ryunosuke Nakagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.